Zimmer Biomet will hire 500 professionals over the next three years for its new Bengaluru technology centre, expanding its AI, software engineering, and R&D capabilities as India strengthens its position as a global healthcare innovation hub.
The post Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation appeared first on MedTech Intelligence.
AdaptHealth is investigating a material cyberattack after attackers used a social engineering scheme to compromise a third-party contractor's account, stealing patient data from its cloud-based systems as reports link the breach to the ShinyHunters extortion group, though the attribution remains unconfirmed.
The post AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges appeared first on MedTech Intelligence.
MTI Viewpoints Insights shared by industry relative to healthcare and the advancement of medical technology. Jaimon Jose, senior director of engineering and compliance at CharmHealth, is a software architect and technical leader with more than 18 years of product development experience in the areas of identity and security technologies, distributed systems, cloud security, and data…
The post Applying Agentic AI to Healthcare Delivery: The Key to True Transformation appeared first on MedTech Intelligence.
Post-market surveillance (PMS) systems in the medical device industry have become increasingly sophisticated in collecting complaints, monitoring adverse events, and generating regulatory reports. However, many organizations still struggle to translate these insights into timely clinical action and meaningful patient safety improvements. This article examines the growing disconnect between regulatory reporting and operational decision-making, explores the challenges of signal detection and prioritization, and outlines practical strategies for building closed-loop PMS systems that improve patient safety outcomes and organizational responsiveness.
The post From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance appeared first on MedTech Intelligence.
By the time most medtech organizations noticed their teams were using AI in regulatory work, the governance conversation was already running behind.. How can your organization move forward? An Operational AI Capability Maturity Model — a five-domain framework built specifically for regulatory affairs and offers a direct way to assess where your organization actually stands. If your team cannot consistently answer who approved the tool, how the output was verified, and what was retained, this framework is a practical place to start.
The post Is Your Organization Ready to Govern AI in Regulatory Affairs? appeared first on MedTech Intelligence.
CMS’s proposed expansion of Medicare TAVR coverage to include select asymptomatic severe aortic stenosis patients and reduce access barriers for symptomatic patients could significantly increase TAVR adoption, creating a growth opportunity for Edwards Lifesciences through expanded eligibility, higher procedure volumes, and continued leadership in structural heart care.
The post CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences appeared first on MedTech Intelligence.
Medtronic announced several regulatory milestones for its Hugo robotic-assisted surgery platform, including FDA submissions for general and gynecologic surgery indications and the LigaSure™ RAS instrument, alongside FDA clearance for its ProGrip™ Advanced hernia mesh. The developments expand the company's robotic surgery portfolio and support its growth strategy in minimally invasive surgical care.
The post Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals appeared first on MedTech Intelligence.
Medtronic reported robust fiscal 2026 results, fueled by strong growth in cardiovascular, medical surgical, and diabetes technologies, while advancing key product launches, regulatory milestones, and strategic acquisitions.
The post Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses appeared first on MedTech Intelligence.
Boston Scientific will invest $138 million to build a 500,000-square-foot global medical device distribution facility in Plainfield, Indiana, creating up to 300 high-wage jobs and expanding the state's growing life sciences sector.
The post Boston Scientific Plans Indiana Distribution Center, 300 New Jobs appeared first on MedTech Intelligence.
The most recent AI thought leadership published on MedTechIntelligence.com.
The post MedTech In Focus: AI impact in healthcare appeared first on MedTech Intelligence.
Why is algorithmic transparency becoming an increasingly important consideration in FDA's review of AI/ML medical devices?
The post If Your AI Can’t Explain Itself, Can FDA Authorize It? appeared first on MedTech Intelligence.
MTI Viewpoints Insights shared by industry relative to healthcare and the advancement of medical technology. Peter Justen is Founder and CEO of AmeriTrust Solutions. He works at the intersection of technology, data, and human-centered design to improve access to government programs and streamline administrative processes. Hospitals and health systems make real-time decisions about patient care,…
The post Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity appeared first on MedTech Intelligence.
How has AI impacted the way in which companies recruit for senior specialists, particularly in highly niche roles in MedTech, biotech and pharmaceutical development? Finding the right people for these roles has never been harder.
The post The failure of the ‘usual suspects’ approach to life science recruitment appeared first on MedTech Intelligence.
Market Access is now the central input into M&A and value-driven divestitures, enabling MedTech leaders to reshape portfolios for strategic advantage, long-term growth, and greater value to patients - unlocking their full potential.
The post Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook. appeared first on MedTech Intelligence.
Boston Children’s Hospital physicians say one of the greatest risks in pediatric ICUs is delayed de-escalation of care, which can expose children to prolonged ventilation, sedation, and vasoactive medications. They argue that AI-driven clinical intelligence can help clinicians identify safer timing for weaning and extubation, supporting recovery and improving long-term outcomes.
The post The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation appeared first on MedTech Intelligence.
Artivion has finalized its acquisition of Endospan Ltd., adding the FDA-approved NEXUS Aortic Arch System to its portfolio of aortic arch therapies. The deal strengthens the company’s position in the growing endovascular aortic repair market and adds a pipeline of next-generation arch technologies.
The post Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System appeared first on MedTech Intelligence.
Tecomet and Orchid Orthopedic Solutions have completed a merger to create a larger global contract manufacturing platform serving MedTech and Aerospace & Defense customers with expanded capabilities and supply chain reach.
The post Global MedTech Contract Manufactures Finalize Merger appeared first on MedTech Intelligence.
Up to 1,000 jobs globally could be cut over the next three years as part of a major restructuring effort following weaker first-half earnings driven by declining sales, currency pressures, and weak market demand.
The post Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort appeared first on MedTech Intelligence.
Marks the first FDA-approved use of personalized molecular residual disease (MRD) testing to guide treatment decisions and solidifies Natera’s Treatment on MRD (TOMR) approach for MIBC care.
The post Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer appeared first on MedTech Intelligence.
Agreement includes exclusive option to acquire novel, balloon-expandable transcatheter aortic valve made with proprietary rhenium alloy
The post Boston Scientific announces strategic investment in MiRus LLC appeared first on MedTech Intelligence.
Innovation, implementation & utilization of medical technology
